CHINA Firm suspends production for 3 months after vaccine scandal

CHINA

Firm suspends production for 3 months after vaccine scandal

Global Times

16:36, July 26, 2018

261635253cfr.jpg

(Photo: VCG)

The vaccine manufacturer that enraged the public for producing invalid rabies vaccines said on Wednesday that it has halted production and cannot operate in the next three months after 15 of its employees were detained.

The Changsheng Biotechnology Corporation, one of the country's major producers of children's vaccines, confirmed on Wednesday it would suspend operations for three months.
Based in Changchun, Northeastern China's Jilin Province, the company has been accused of illegally manufacturing fake and invalid rabies vaccines for human use, as well as substandard DPT vaccines against diphtheria, pertussis or whooping cough, and tetanus for children.
The news came after police detained 15 people from the company on Tuesday, including Gao Junfang, the company chairman.
After the company was exposed for producing invalid vaccines, another vaccine company, the Wuhan Institute of Biological Product Co., Ltd. was reportedly selling 400,000 substandard DPT vaccines in Chongqing and Hebei Province, according to a China National Radio report on Wednesday.
The Hebei authority had confirmed the information but the Chongqing government failed to comment as of press time, the report said.
China has 40 vaccine manufacturers capable of producing 60 types of vaccines to prevent 34 types of infectious diseases. Domestic vaccines account for more than 95 percent of vaccinations, The Beijing News reported.
Experts said domestically-manufactured vaccines and imported vaccines are virtually identical, but that the domestic ones are cheaper, the report said.

Related Stories

Terms of Service & Privacy Policy

We have updated our privacy policy to comply with the latest laws and regulations. The updated policy explains the mechanism of how we collect and treat your personal data. You can learn more about the rights you have by reading our terms of service. Please read them carefully. By clicking AGREE, you indicate that you have read and agreed to our privacy policies

Agree and continue